S2S China Announces 2026 Finalists, Ten Standout Teams Set to Pitch Global Investors at Westlake University
SHANGHAI, Sept. 20, 2026 /PRNewswire/ -- The inaugural S2S China Symposium has announced the finalists of its 2026 program. Co-hosted by RA Capital Management and Qiming Venture Partners, S2S China is the China chapter of Science2Startup, an...
AlphaPai Raises US$50 Million in Series B Funding as Financial AI Moves into the Depths of Professional Work
HONG KONG, Sept. 15, 2026 /PRNewswire/ -- AlphaPai, an AI investment research assistant developed by the financial AI company Rabyte Technology for professional investors, today announced the completion of a Series B funding round of US$50 million....
Global-Leading Robobrain Firm Mech-Mind Robotics Lists on Hong Kong Stock Exchange
SHANGHAI, Sept. 1, 2026 /PRNewswire/ -- Mech-Mind Robotics, a portfolio company of Qiming Venture Partners and a global-leading robobrain company, successfully listed on the Hong Kong Stock Exchange on September 1, 2026 Beijing time and became the...
Chinese X-by-Wire Chassis Leader NASN Intelligent Tech Lists on Hong Kong Stock Exchange
SHANGHAI, Aug. 7, 2026 /PRNewswire/ -- NASN Intelligent Tech, a portfolio company of Qiming Venture Partners and Chinese X-by-wire chassis leader, successfully listed on the Hong Kong Stock Exchange on August 7, 2026 Beijing time. NASN Intelligent...
Immune Mediated Disease Therapeutics Developer Attovia Therapeutics Debuts on Nasdaq
SHANGHAI, Aug. 6, 2026 /PRNewswire/ -- Attovia Therapeutics, a portfolio company of Qiming Venture Partners and clinical-stage biopharmaceutical leader, successfully listed on the Nasdaq on August 5, 2026 Beijing time. Attovia Therapeutics (Nasdaq:...
China's Leading Innovative Drug Developer for Allergic and Autoimmune Diseases LongBio Pharma Lists on Hong Kong Stock Exchange
SHANGHAI, June 5, 2026 /PRNewswire/ -- LongBio Pharma, a portfolio company of Qiming Venture Partners and a leading innovative drug developer for allergic and autoimmune diseases in China, listed on the Hong Kong Stock Exchange on June 5, 2026...
Qiming Venture Partners Managing Partner Alex Zhou Named to 2026 Forbes Midas List
SHANGHAI, May 29, 2026 /PRNewswire/ -- Forbes has released its 2026 Midas List, the definitive ranking of the world's top venture capital investors. Alex Zhou, Managing Partner at Qiming Venture Partners, debuts at No. 80, recognizing his track...
Domestic Display Chip Leader Viewtrix Technology Listed on Hong Kong Stock Exchange
SHANGHAI, May 27, 2026 /PRNewswire/ -- Viewtrix Technology, a portfolio company of Qiming Venture Partners and a leading display chip design enterprise in China, successfully listed on the Hong Kong Stock Exchange, marking the sixth IPO for Qiming...
Precision Proteomics Leader Alamar Biosciences Lists on NASDAQ
SHANGHAI, April 20, 2026 /PRNewswire/ -- Alamar Biosciences, a portfolio company of Qiming Venture Partners and a global leader in precision proteomics, successfully listed on the NASDAQ Stock Exchange on April 17th, 2026, Beijing Time. Alamar...
Pulnovo Medical Announces Strategic Investment from Medtronic in oversubscribed $100 Million Financing Round
NEW YORK, April 20, 2026 /PRNewswire/ -- Pulnovo Medical, a pioneer in breakthrough therapies for treating Pulmonary Hypertension and Heart Failure, today announced the successful completion of an oversubscribed $100 million strategic financing...